T cell redirecting therapy for relapsed multiple myeloma
Abstract In recent years, the utilization of immunomodulatory drugs, proteasome inhibitors and CD38 targeting monoclonal antibodies has led to significant improvements in the overall outcomes of patients with multiple myeloma. Despite these advances, relapse remains common, and until recently, the p...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-08-01
|
| Series: | Discover Oncology |
| Online Access: | https://doi.org/10.1007/s12672-025-03432-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|